LILRB4 and acute myeloid leukemia: Since AKT/mTOR and ERK/mTOR pathways were significantly affected after the downregulation of PRMT5 in AML cell lines, we speculated that PRMT5 might affect the expression of LILRB4 and the invasive capability of AML cells through AKT/mTOR and ERK/mTOR axes.